GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com


Jump to: navigation, search

Roose, JP, Mollenauer, M, Gupta, VA, Stone, J and Weiss, A (2005) A diacylglycerol-protein kinase C-RasGRP1 pathway directs Ras activation upon antigen receptor stimulation of T cells. Mol. Cell. Biol. 25:4426-41


Ras GTPases are on/off switches regulating numerous cellular responses by signaling to various effector molecules. In T lymphocytes, Ras can be activated by two Ras exchange factors, SOS and RasGRP1, which are recruited through the adapters Grb2 and LAT and via the second-messenger diacylglycerol (DAG), respectively. Mitogen-activated protein (MAP) kinase phosphorylation patterns induced by active Ras can vary and contribute to distinct cellular responses. The different consequences of Ras activation by either guanine exchange factor are unknown. DAG also recruits and activates the kinase protein kinase Ctheta (PKCtheta) turning on the Erk MAP kinase pathway, but the biochemical mechanism responsible is unclear. We generated T-cell clones deficient in phorbol myristate acetate (a surrogate for DAG)-induced Ras activation. Analysis of a RasGRP1-deficient Jurkat T-cell clone and RasGRP1 RNA interference in wild-type cells revealed that RasGRP1 is required for optimal, antigen receptor-triggered Ras-Erk activation. RasGRP1 relies on its DAG-binding domain to selectively activate Erk kinases. Activation of Erk correlates with the phosphorylation of threonine residue 184 in RasGRP1. This phosphorylation event requires the activities of novel PKC kinases. Conversely, active PKCtheta depends on RasGRP1 sufficiency to effectively trigger downstream events. Last, DAG-PKC-RasGRP1-driven Ras-Erk activation in T cells is a unique signaling event, not simply compensated for by SOS activity.


PubMed PMC1140631 Online version:10.1128/MCB.25.11.4426-4441.2005


Acetophenones/pharmacology; Antigens, CD/metabolism; Antigens, Differentiation, T-Lymphocyte/metabolism; Benzopyrans/pharmacology; Calcium/metabolism; DNA-Binding Proteins/deficiency; DNA-Binding Proteins/genetics; DNA-Binding Proteins/metabolism; Diglycerides/metabolism; Enzyme Activation; Guanine Nucleotide Exchange Factors/deficiency; Guanine Nucleotide Exchange Factors/genetics; Guanine Nucleotide Exchange Factors/metabolism; Humans; Isoenzymes/antagonists & inhibitors; Isoenzymes/metabolism; Jurkat Cells; Lectins, C-Type; Mitogen-Activated Protein Kinase 1/metabolism; Mitogen-Activated Protein Kinase 3/metabolism; Phosphorylation; Protein Kinase C/antagonists & inhibitors; Protein Kinase C/metabolism; Protein Kinase Inhibitors/pharmacology; RNA Interference; Receptors, Antigen, T-Cell, alpha-beta/metabolism; Signal Transduction; T-Lymphocytes/drug effects; T-Lymphocytes/enzymology; T-Lymphocytes/immunology; Tetradecanoylphorbol Acetate/pharmacology; ras GTPase-Activating Proteins/genetics; ras GTPase-Activating Proteins/metabolism; ras Proteins/metabolism



Gene product Qualifier GO Term Evidence Code with/from Aspect Extension Notes Status


GO:0043406: positive regulation of MAP kinase activity



Fig 4B. Erk1/Erk2 phosphorylation (via MAPK) was delayed and reduced in RasGRP1- mutants.

CACAO 2101



GO:0043406: positive regulation of MAP kinase activity

ECO:0000315: mutant phenotype evidence used in manual assertion


Seeded From UniProt


See also


See Help:References for how to manage references in GONUTS.